Author: "Dahle, Jostein" / Journal: journal of nuclear medicine - Searchworks@Jio Institute Digital Library Search Results

Searchworks

Select search scope, currently: Articles

Catalog

books, media & more in Jio Institute collections

Articles

journal articles & other e-resources

Your search keyword '"Dahle, Jostein"' showing total 8 results

Start Over Author "Dahle, Jostein" Journal journal of nuclear medicine

8 results on '"Dahle, Jostein"'

1. 177Lu-Lilotomab Satetraxetan Has the Potential to Counteract Resistance to Rituximab in Non-Hodgkin Lymphoma

Author: Malenge, Marion M., primary, Patzke, Sebastian, additional, Ree, Anne H., additional, Stokke, Trond, additional, Ceuppens, Peter, additional, Middleton, Brian, additional, Dahle, Jostein, additional, and Repetto-Llamazares, Ada H.V., additional
Published: 2020
Full Text: View/download PDF

2. 177Lu-lilotomab satetraxetan has the potential to counteract resistance to rituximab in non- Hodgkin's lymphoma.

Author: Malenge, Marion M., Patzke, Sebastian, Ree, Anne H., Stokke, Trond, Ceuppens, Peter, Middleton, Brian, Dahle, Jostein, and Repetto-Llamazares, Ada H. V.
Published: 2020
Full Text: View/download PDF

3. Biodistribution and Dosimetry Results from a Phase 1 Trial of Therapy with the Antibody–Radionuclide Conjugate177Lu-Lilotomab Satetraxetan

Author: Blakkisrud, Johan, primary, Holtedahl, Jon Erik, additional, Løndalen, Ayca, additional, Dahle, Jostein, additional, Bach-Gansmo, Tore, additional, Holte, Harald, additional, Nygaard, Stine, additional, Kolstad, Arne, additional, and Stokke, Caroline, additional
Published: 2017
Full Text: View/download PDF

4. Red Marrow–Absorbed Dose for Non-Hodgkin Lymphoma Patients Treated with 177Lu-Lilotomab Satetraxetan, a Novel Anti-CD37 Antibody–Radionuclide Conjugate

Author: Blakkisrud, Johan, primary, Løndalen, Ayca, additional, Dahle, Jostein, additional, Turner, Simon, additional, Holte, Harald, additional, Kolstad, Arne, additional, and Stokke, Caroline, additional
Published: 2016
Full Text: View/download PDF

5. Tumor-Absorbed Dose for Non-Hodgkin Lymphoma Patients Treated with the Anti-CD37 Antibody Radionuclide Conjugate 177Lu-Lilotomab Satetraxetan

Author: Blakkisrud, Johan, primary, Løndalen, Ayca, additional, Martinsen, Anne C.T., additional, Dahle, Jostein, additional, Holtedahl, Jon E., additional, Bach-Gansmo, Tore, additional, Holte, Harald, additional, Kolstad, Arne, additional, and Stokke, Caroline, additional
Published: 2016
Full Text: View/download PDF

6. Biodistribution and Dosimetry Results from a Phase 1 Trial of Therapy with the Antibody-Radionuclide Conjugate 177Lu-Lilotomab Satetraxetan.

Author: Blakkisrud, Johan, Holtedahl, Jon Erik, Løndalen, Ayca, Dahle, Jostein, Bach-Gansmo, Tore, Holte, Harald, Nygaard, Stine, Kolstad, Arne, and Stokke, Caroline
Published: 2018
Full Text: View/download PDF

7. Red Marrow–Absorbed Dose for Non-Hodgkin Lymphoma Patients Treated with 177Lu-Lilotomab Satetraxetan, a Novel Anti-CD37 Antibody–Radionuclide Conjugate.

Author: Blakkisrud, Johan, Løndalen, Ayca, Dahle, Jostein, Turner, Simon, Holte, Harald, Kolstad, Arne, and Stokke, Caroline
Published: 2017
Full Text: View/download PDF

8. Tumor-Absorbed Dose for Non-Hodgkin Lymphoma Patients Treated with the Anti-CD37 Antibody Radionuclide Conjugate 177Lu-Lilotomab Satetraxetan.

Author: Blakkisrud, Johan, Løndalen, Ayca, Martinsen, Anne C. T., Dahle, Jostein, Holtedahl, Jon E., Bach-Gansmo, Tore, Holte, Harald, Kolstad, Arne, and Stokke, Caroline
Published: 2017
Full Text: View/download PDF

Catalog

Books, media, physical & digital resources

See catalog results